Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)

被引:104
作者
Rolfe, M
McLeod, LE
Pratt, PF
Proud, CG
机构
[1] Univ Dundee, Div Mol Physiol, Sch Life Sci, Dundee DD1 5EH, Scotland
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
关键词
extracellular-signal-regulated kinase (ERK); hypertrophy; Mnk; mTOR; myocyte; protein synthesis;
D O I
10.1042/BJ20041888
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hypertrophic G(q)-protein-coupled receptor agonist PE (phenylephrine) activates protein synthesis. We showed previously that activation of protein synthesis by PE requires MEK [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase] and mTOR (mammalian target of rapamycin). However, it remained unclear whether ERK activation was required and which downstream components were involved in activating mTOR and protein synthesis. Using an adenovirus encoding the MKP3 (MAPK phosphatase 3) to inhibit ERK activity, we demonstrate that ERK is essential for the activation of protein synthesis by PE. Activation and phosphorylation of S6K1 (ribosomal protein S6 kinase 1) and phosphorylation of eIF4E (eukaryotic initiation factor 4E)-binding protein (both are mTOR targets) were also inhibited by MKP3, suggesting that ERK is also required for the activation of mTOR signalling. PE stimulation of cardiomyocytes induced the phosphorylation of TSC2 (tuberous sclerosis complex 2), a negative regulator of mTOR activity. TSC2 was phosphorylated only weakly at Thr(1462), but phosphorylated at additional sites within the sequence RXRXX(S/T). This differs from the phosphorylation induced by insulin, indicating that MEK/ERK signalling targets distinct sites in TSC2. This phosphorylation may be mediated by p90(RSK) (90 kDa ribosomal protein S6K), which is activated by ERK, and appears to involve phosphorylation at Ser(1798). Activation of protein synthesis by PE is partially insensitive to the mTOR inhibitor rapamycin. Inhibition of the MAPK-interacting kinases by CGP57380 decreases the phosphorylation of eIF4E and PE-induced protein synthesis. Moreover, CGP57380 + rapamycin inhibited protein synthesis to the same extent as blocking ERK activation, suggesting that MAPK-interacting kinases and regulation of mTOR each contribute to the activation of protein synthesis by PE in cardiomyocytes.
引用
收藏
页码:973 / 984
页数:12
相关论文
共 57 条
[1]   Molecular basis for the substrate specificity of protein kinase B; Comparison with MAPKAP kinase-1 and p70 S6 kinase [J].
Alessi, DR ;
Caudwell, FB ;
Andjelkovic, M ;
Hemmings, BA ;
Cohen, P .
FEBS LETTERS, 1996, 399 (03) :333-338
[2]   Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo [J].
Antos, CL ;
McKinsey, TA ;
Frey, N ;
Kutschke, W ;
McAnally, J ;
Shelton, JM ;
Richardson, JA ;
Hill, JA ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :907-912
[3]  
Avruch J, 2001, Prog Mol Subcell Biol, V26, P115
[4]   Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors [J].
Ballif, BA ;
Roux, PP ;
Gerber, SA ;
MacKeigan, JP ;
Blenis, J ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :667-672
[5]   MAP2 KINASE AND 70K-S6 KINASE LIE ON DISTINCT SIGNALING PATHWAYS [J].
BALLOU, LM ;
LUTHER, H ;
THOMAS, G .
NATURE, 1991, 349 (6307) :348-350
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death [J].
Bueno, OF ;
Molkentin, JD .
CIRCULATION RESEARCH, 2002, 91 (09) :776-781
[8]   The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo [J].
Bueno, OF ;
De Windt, LJ ;
Lim, HW ;
Tymitz, KM ;
Witt, SA ;
Kimball, TR ;
Molkentin, JD .
CIRCULATION RESEARCH, 2001, 88 (01) :88-96
[9]   Dual specificity phosphatases: a gene family for control of MAP kinase function [J].
Camps, M ;
Nichols, A ;
Arkinstall, S .
FASEB JOURNAL, 2000, 14 (01) :6-16
[10]   The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin [J].
Cocolakis, E ;
Lemay, S ;
Ali, S ;
Lebrun, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18430-18436